文献速递乳腺外科围术期管理与 ERAS

化疗与即刻乳房重建并发症及患者报告结局的关联

Association of Clinical Complications of Chemotherapy and Patient-Reported Outcomes After Immediate Breast Reconstruction.
PubMed 文献 · JAMA Surg · 2021-01-01

该队列研究纳入1881例即刻乳房重建女性,前瞻性评估BREAST-Q患者报告结局并回顾性评估并发症,比较新辅助化疗、辅助化疗与无化疗组的差异。多变量分析显示化疗与植入物或自体重建的并发症风险无关,除植入物重建组辅助化疗者性健康评分较低外,化疗与重建满意度及心理社会健康无关。

要点

  • 化疗与即刻乳房重建并发症风险无独立关联
  • 辅助化疗者植入物重建的性健康评分较低
  • 结果可辅助化疗背景下乳房重建的决策沟通

核心结论

  • 在新辅助或辅助化疗下,即刻植入物或自体乳房重建的并发症风险与化疗无显著关联,化疗也未影响重建满意度与心理社会健康。

研究设计与样本

  • Mastectomy Reconstruction Outcomes Consortium 前瞻性队列研究,纳入2012年1月1日至2017年12月31日11个中心1881例即刻乳房重建女性,前瞻评估患者报告结局,回顾评估并发症。

主要发现

  • 植入物重建组任何并发症率在新辅助化疗28.8%、辅助化疗31.2%、无化疗24.1%间存在差异(P = .02),但多变量分析后差异不显著。
  • 自体重建组并发症无显著差异。
  • BREAST-Q各子量表在化疗组间无显著差异,仅植入物组辅助化疗的性健康评分较低(β,-4.97 [95%CI,-8.68至-1.27];P = .009)。

临床怎么用

  • 向拟行即刻乳房重建的患者说明化疗不增加并发症风险且不降低重建满意度,可支持化疗背景下重建决策。

局限性

  • 为观察性队列研究,并发症回顾性评估,且化疗组更多接受放疗,可能存在混杂。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Women undergoing immediate breast reconstruction often require chemotherapy. The effects of chemotherapy on reconstruction are not well described. OBJECTIVE: To evaluate the association of neoadjuvant and adjuvant chemotherapy with complications and patient-reported outcomes (PROs) in immediate reconstruction. DESIGN, SETTING, AND PARTICIPANTS: The Mastectomy Reconstruction Outcomes Consortium Study is a cohort study that prospectively assessed PROs and retrospectively evaluated complications in patients undergoing immediate implant-based or autologous reconstruction at 11 centers from January 1, 2012, to December 31, 2017. Women 18 years or older undergoing immediate reconstruction after mastectomy with 2 years of follow-up were included. Patients were excluded if they had prophylactic mastectomy; delayed reconstruction; mixed-timing reconstruction; mixed reconstruction; a latissimus dorsi, superior gluteal artery perforator, or inferior gluteal artery perforator flap; or both neoadjuvant and adjuvant chemotherapy. Data were analyzed from May 1 to June 30, 2018. MAIN OUTCOMES AND MEASURES: Complications and PROs (satisfaction with breast and physical, psychosocial, and sexual well-being) using the BREAST-Q questionnaire, a validated, condition-specific PRO measure. Baseline patient characteristics were collected. RESULTS: A total of 1881 women were included in the analysis (mean [SD] age, 49.9 [9.9] years). Of these, 1373 (73.0%) underwent implant-based procedures; 508 (27.0%), autologous reconstruction; 200 (10.6%), neoadjuvant chemotherapy; 668 (35.5%), adjuvant chemotherapy; and 1013 (53.9%), no chemotherapy. Patients without chemotherapy were significantly older (mean [SD] age, 51.6 [9.4] years; P < .001), and patients with chemotherapy were more likely to have received radiotherapy (108 of 200 [54.0%] for neoadjuvant chemotherapy and 321 of 668 [48.1%] for adjuvant chemotherapy; P < .001). Among the cohort undergoing implant-based reconstruction, the rates of any complication were significantly different, with higher rates seen for adjuvant (153 of 490 [31.2%]) and neoadjuvant (44 of 153 [28.8%]) chemotherapy compared with no chemotherapy (176 of 730 [24.1%]; P = .02). On multivariable analysis, these differences were not statistically significant. For autologous reconstruction, no significant differences in complications were observed. Controlling for clinical covariates, no significant differences were seen across chemotherapy groups for the BREAST-Q subscales except for sexual well-being in the implant cohort, in which adjuvant chemotherapy had significantly lower scores (β, -4.97 [95% CI, -8.68 to -1.27]; P = .009). CONCLUSIONS AND RELEVANCE: In this cohort study, neither neoadjuvant nor adjuvant chemotherapy was associated with the likelihood of complications in patients undergoing implant-based or autologous reconstruction, and chemotherapy was not associated with patient satisfaction with reconstruction or psychosocial well-being. This information can help patients and clinicians make informed decisions about breast reconstruction in the setting of chemotherapy.

来源:JAMA Surg,查看原文。版权归原作者所有。

引用

  1. Hart SE, Brown DL, Kim HM, et al. Association of Clinical Complications of Chemotherapy and Patient-Reported Outcomes After Immediate Breast Reconstruction. JAMA Surg. 2021. PMID: 34160601. doi:10.1001/jamasurg.2021.2239

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。